Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Total Current Liabilities (2023 - 2025)

Bioharvest Sciences has reported Total Current Liabilities over the past 3 years, most recently at $7.7 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 46.11% year-over-year to $7.7 million; the TTM value through Dec 2025 reached $7.7 million, down 46.11%, while the annual FY2025 figure was $7.7 million, 46.11% down from the prior year.
  • Total Current Liabilities was $7.7 million for Q4 2025 at Bioharvest Sciences, down from $13.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $26.5 million in Q4 2023 and bottomed at $7.7 million in Q4 2025.
  • The 3-year median for Total Current Liabilities is $14.3 million (2024), against an average of $14.5 million.
  • Year-over-year, Total Current Liabilities tumbled 46.13% in 2024 and then skyrocketed 91.37% in 2025.
  • Over 3 years, Total Current Liabilities stood at $26.5 million in 2023, then tumbled by 46.13% to $14.3 million in 2024, then plummeted by 46.11% to $7.7 million in 2025.
  • The last three reported values for Total Current Liabilities were $7.7 million (Q4 2025), $13.2 million (Q3 2025), and $17.1 million (Q2 2025) per Business Quant data.